EFFECTS OF THE AGGREGATION STATE OF AMPHOTERICIN-B ON ITS TOXICITY TO MICE

被引:155
作者
BARWICZ, J [1 ]
CHRISTIAN, S [1 ]
GRUDA, I [1 ]
机构
[1] UNIV QUEBEC, DEPT CHIM BIOL, CP 500, TROIS RIVIERES GA9 5H7, QUEBEC, CANADA
关键词
D O I
10.1128/AAC.36.10.2310
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Amphotericin B (AmB) is a very effective antifungal agent for most systemic fungal infections. However, the relatively high toxicity of this drug imposes limits on its clinical usefulness. Most of the current work in this field is devoted to the search for less-toxic formulations of the drug. Here we describe the effects of three surfactants, one anionic and the other two nonionic, on the aggregation state of AmB in solutions which were injected intravenously into mice. The degree of aggregation of AmB was monitored spectroscopically and by light scattering. The toxicity was expressed as percentage of survivors. These results were compared with those obtained with doses of AmB the same as those present in a commercial formulation of AmB, Fungizone. Two surfactants, lauryl sucrose and sodium deoxycholate, used at concentrations which induced monomerization of AmB, substantially decreased the acute toxicity of AmB to mice. Conversely, the third surfactant, Tween 80, showed a synergistic potentiation of the toxicity of the antibiotic. A good correlation was found between the in vivo toxicity and the aggregation state of AmB in injected solutions. Solutions in which AmB was almost entirely monomeric were half as toxic after 24 h and about six times less toxic after 1 week than the corresponding solutions of Fungizone.
引用
收藏
页码:2310 / 2315
页数:6
相关论文
共 22 条
  • [1] TREATMENT OF MURINE CANDIDOSIS AND CRYPTOCOCCOSIS WITH A UNILAMELLAR LIPOSOMAL AMPHOTERICIN-B FORMULATION (AMBISOME)
    ADLERMOORE, JP
    CHIANG, SM
    SATORIUS, A
    GUERRA, D
    MCANDREWS, B
    MCMANUS, EJ
    PROFFITT, RT
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 : 63 - 71
  • [2] INHIBITION OF THE INTERACTION BETWEEN LIPOPROTEINS AND AMPHOTERICIN-B BY SOME DELIVERY SYSTEMS
    BARWICZ, J
    GAREAU, R
    AUDET, A
    MORISSET, A
    VILLIARD, J
    GRUDA, I
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 181 (02) : 722 - 728
  • [3] ONE-SIDED ACTION OF AMPHOTERICIN-B ON CHOLESTEROL-CONTAINING MEMBRANES IS DETERMINED BY ITS SELF-ASSOCIATION IN THE MEDIUM
    BOLARD, J
    LEGRAND, P
    HEITZ, F
    CYBULSKA, B
    [J]. BIOCHEMISTRY, 1991, 30 (23) : 5707 - 5715
  • [4] LIPOSOMAL AMPHOTERICIN-B (AMBISOME) IN THE TREATMENT OF FUNGAL-INFECTIONS IN NEUTROPENIC PATIENTS
    CHOPRA, R
    BLAIR, S
    STRANG, J
    CERVI, P
    PATTERSON, KG
    GOLDSTONE, AH
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 : 93 - 104
  • [5] LIPID EMULSIONS AS DRUG DELIVERY SYSTEMS
    DAVIS, SS
    WASHINGTON, C
    WEST, P
    ILLUM, L
    LIVERSIDGE, G
    STERNSON, L
    KIRSH, R
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 507 : 75 - 88
  • [6] DIAMOND RD, 1991, REV INFECT DIS, V13, P480
  • [7] EFFECT OF THE AGGREGATION STATE OF AMPHOTERICIN-B ON ITS INTERACTION WITH ERGOSTEROL
    GRUDA, I
    DUSSAULT, N
    [J]. BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1988, 66 (03): : 177 - 183
  • [8] EFFECTS OF THE DETERGENT SUCROSE MONOLAURATE ON BINDING OF AMPHOTERICIN-B TO STEROLS AND ITS TOXICITY FOR CELLS
    GRUDA, I
    GAUTHIER, E
    ELBERG, S
    BRAJTBURG, J
    MEDOFF, G
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 154 (03) : 954 - 958
  • [9] STRUCTURE-ACTIVITY STUDY OF INHIBITION OF AMPHOTERICIN-B (FUNGIZONE) BINDING TO STEROLS, TOXICITY TO CELLS, AND LETHALITY TO MICE BY ESTERS OF SUCROSE
    GRUDA, I
    MILETTE, D
    BROTHER, M
    KOBAYASHI, GS
    MEDOFF, G
    BRAJTBURG, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (01) : 24 - 28
  • [10] JULIANO RL, 1987, MOL PHARMACOL, V31, P1